Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hormonally Balanced vs Medsol RX

Hormonally Balanced
Graded #412

Lower grade

vs+4.600000000000001
Medsol RX
Graded #306

Higher grade

The verdict

Medsol RX takes it — 61/100 to 56.4/100.

Medsol RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medsol RX is a GLP-1 weight-loss telehealth program offering compounded semaglutide (from $209/mo) and tirzepatide, prescribed by board-certified clinicians via OpenLoop and shipped nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationMedsol RX +24
40
64
Clinical oversightHormonally Balanced +1
80
79
Labs & monitoringEven
53
53
FulfillmentMedsol RX +10
73
83
Contract termsHormonally Balanced +14
55
41
Hormonally Balanced · left barMedsol RX · right bar

The numbers

MetricHormonally BalancedMedsol RX
WeighScore56.4/10061/100
GradeCC
Scorecard rank#412#306
SemaglutideNot disclosed$209/mo (compounded)
TirzepatideNot disclosed$250/mo (compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Hormonally Balanced

Graded #412 · C

Strengths

  • Physician-led women's hormone clinic with concierge model
  • Nationwide telehealth availability
  • Semaglutide integrated with hormone care for women
  • Named physician (Dr. Zachareas) oversees prescriptions

Where it loses points

  • No pricing published online; must call or submit a form
  • Weight loss is secondary to menopause/hormone focus
  • Semaglutide only; no tirzepatide listed
  • Compounded vs brand formulation not disclosed
Medsol RX

Graded #306 · C

Strengths

  • Compounded semaglutide from $209/mo (12-mo plan) and tirzepatide from ~$250/mo; HSA/FSA eligible with Klarna financing
  • Every plan bundles the medication, a dedicated care coach, custom treatment plan, medical oversight, and free shipping
  • Board-certified clinicians via OpenLoop; same-day approvals; ships nationwide
  • Month-to-month option ($199 first month) with no long-term commitment, plus microdosing and wellness add-ons

Where it loses points

  • Doesn't name its compounding pharmacy (generic 'certified U.S. pharmacies')
  • No legal entity name published on the site
  • Tirzepatide pricing is given as a range ($250-$1,400/mo), not a fixed rate
  • Compounded GLP-1s are not FDA-approved (the site discloses this)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard